Woodline Partners LP Aclaris Therapeutics, Inc. Transaction History

Woodline Partners LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.56 - $10.95 $450,875 - $752,604	68,731 Added 67.72%	170,230 $1.17 Million
Q2 2023 Aug 14, 2023	SELL	$7.89 - $10.64 $983,906 - $1.33 Million	-124,703 Reduced 55.13%	101,499 $1.05 Million
Q1 2023 May 15, 2023	SELL	$7.07 - $17.95 $2.66 Million - $6.75 Million	-376,317 Reduced 62.46%	226,202 $1.83 Million
Q4 2022 Feb 14, 2023	SELL	$14.33 - $18.37 $1.35 Million - $1.74 Million	-94,488 Reduced 13.56%	602,519 $9.49 Million
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $986,131 - $1.37 Million	75,450 Added 12.14%	697,007 $11 Million
Q2 2022 Aug 15, 2022	BUY	$10.16 - $17.08 $6.32 Million - $10.6 Million	621,557 New	621,557 $8.68 Million
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.49 $7.3 Million - $11 Million	-594,768 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.38 - $18.8 $7.96 Million - $11.2 Million	594,768 New	594,768 $10.7 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $193M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.